Chidamide, Venetoclax, and Azacitidine for Newly Diagnosed Acute Myeloid Leukemia — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Chidamide, Venetoclax, and Azacitidine for Newly Diagnosed Acute Myeloid Leukemia — Stella

View on ClinicalTrials.gov

Recruiting

Back to AML trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

Blood Hospital, Tianjin, Tianjin Municipality

Key details

Sponsor

Institute of Hematology & Blood Diseases Hospital, China

Enrollment target

~184 participants

Started

August 2024

Primary completion

December 2027

Age range

18 Years and older

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.